Literature DB >> 23439482

The vascular depression hypothesis: mechanisms linking vascular disease with depression.

W D Taylor1, H J Aizenstein, G S Alexopoulos.   

Abstract

The 'Vascular Depression' hypothesis posits that cerebrovascular disease may predispose, precipitate or perpetuate some geriatric depressive syndromes. This hypothesis stimulated much research that has improved our understanding of the complex relationships between late-life depression (LLD), vascular risk factors, and cognition. Succinctly, there are well-established relationships between LLD, vascular risk factors and cerebral hyperintensities, the radiological hallmark of vascular depression. Cognitive dysfunction is common in LLD, particularly executive dysfunction, a finding predictive of poor antidepressant response. Over time, progression of hyperintensities and cognitive deficits predicts a poor course of depression and may reflect underlying worsening of vascular disease. This work laid the foundation for examining the mechanisms by which vascular disease influences brain circuits and influences the development and course of depression. We review data testing the vascular depression hypothesis with a focus on identifying potential underlying vascular mechanisms. We propose a disconnection hypothesis, wherein focal vascular damage and white matter lesion location is a crucial factor, influencing neural connectivity that contributes to clinical symptomatology. We also propose inflammatory and hypoperfusion hypotheses, concepts that link underlying vascular processes with adverse effects on brain function that influence the development of depression. Testing such hypotheses will not only inform the relationship between vascular disease and depression, but also provide guidance on the potential repurposing of pharmacological agents that may improve LLD outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23439482      PMCID: PMC3674224          DOI: 10.1038/mp.2013.20

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  304 in total

1.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

2.  Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implications.

Authors:  Noa Vardi; Nanette Freedman; Hava Lester; John M Gomori; Roland Chisin; Bernard Lerer; Omer Bonne
Journal:  Psychiatry Res       Date:  2011-04-11       Impact factor: 3.222

Review 3.  Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions.

Authors:  D C Steffens; K R Krishnan
Journal:  Biol Psychiatry       Date:  1998-05-15       Impact factor: 13.382

4.  The I/D polymorphism of angiotensin-converting enzyme gene in major depressive disorder and therapeutic outcome: a case-control study and meta-analysis.

Authors:  Yanfeng Wu; Xiaoquan Wang; Xinhua Shen; Zhaoan Tan; Yonggui Yuan
Journal:  J Affect Disord       Date:  2011-10-28       Impact factor: 4.839

5.  Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression.

Authors:  María J Marquine; Deborah K Attix; Larry B Goldstein; Gregory P Samsa; Martha E Payne; Gordon J Chelune; David C Steffens
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

6.  Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

Authors:  B K Saxby; F Harrington; K A Wesnes; I G McKeith; G A Ford
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

7.  Incidence of silent cerebral infarction in patients with major depression.

Authors:  T Fujikawa; S Yamawaki; Y Touhouda
Journal:  Stroke       Date:  1993-11       Impact factor: 7.914

8.  Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors.

Authors:  Warren D Taylor; James R MacFall; James M Provenzale; Martha E Payne; Douglas R McQuoid; David C Steffens; K Ranga Rama Krishnan
Journal:  AJR Am J Roentgenol       Date:  2003-08       Impact factor: 3.959

9.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

Review 10.  White matter hyperintensities in late life depression: a systematic review.

Authors:  L L Herrmann; M Le Masurier; K P Ebmeier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-23       Impact factor: 10.154

View more
  221 in total

1.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

2.  Association of Hearing Impairment and Emotional Vitality in Older Adults.

Authors:  Kevin J Contrera; Josh Betz; Jennifer A Deal; Janet S Choi; Hilsa N Ayonayon; Tamara Harris; Elizabeth Helzner; Kathryn R Martin; Kala Mehta; Sheila Pratt; Susan M Rubin; Suzanne Satterfield; Kristine Yaffe; Melissa Garcia; Eleanor M Simonsick; Frank R Lin
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2016-02-16       Impact factor: 4.077

Review 3.  Cognitive functioning and late-life depression.

Authors:  Aaron M Koenig; Rishi K Bhalla; Meryl A Butters
Journal:  J Int Neuropsychol Soc       Date:  2014-03-31       Impact factor: 2.892

4.  Brain structural connectivity in late-life major depressive disorder.

Authors:  Stephen F Smagula; Howard J Aizenstein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

Review 5.  Perspectives on the Management of Vascular Depression.

Authors:  Warren D Taylor; Susan K Schultz; Vanessa Panaite; David C Steffens
Journal:  Am J Psychiatry       Date:  2018-12-01       Impact factor: 18.112

6.  Sleep Architecture and Mental Health Among Community-Dwelling Older Men.

Authors:  Stephen F Smagula; Charles F Reynolds; Sonia Ancoli-Israel; Elizabeth Barrett-Connor; Thuy-Tien Dam; Jan M Hughes-Austin; Misti Paudel; Susan Redline; Katie L Stone; Jane A Cauley
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2013-12-10       Impact factor: 4.077

7.  Intensive control of hypertension and risk of Alzheimer's dementia in older adults with depression.

Authors:  Anthony Yeung; Alex Kiss; Damien Gallagher
Journal:  Int J Geriatr Psychiatry       Date:  2020-04-21       Impact factor: 3.485

Review 8.  Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

Authors:  Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

9.  Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.

Authors:  Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein
Journal:  J Clin Psychiatry       Date:  2018-10-23       Impact factor: 4.384

10.  Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression.

Authors:  H A Eyre; H Lavretsky; J Kartika; A Qassim; B T Baune
Journal:  Pharmacopsychiatry       Date:  2016-03-07       Impact factor: 5.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.